Home
- Lectures
- Biomedical Translation Research Center
- Location
International Conference Hall (Rm201), Bldg. C, NBRP
- Speaker Name
Dr. Lih-Ling Lin (CSO, PharmaEssentia Corp.)
- State
Definitive
- Url
Targeting Checkpoint Receptors to Develop Novel Immunotherapies in Treating Immunology and Inflammatory Diseases
2023-03-30 10:30 - 12:00
[BioTReC Seminar]
Targeting Checkpoint Receptors to Develop Novel Immunotherapies in Treating Immunology and Inflammatory Diseases
國家生技研究園區特別邀請藥華醫藥科學長林俐伶博士蒞臨演講，林科學長曾任波士頓Sanofi公司免疫學及炎症研究領域的檢查點免疫學群負責人，並曾長期在Pfizer擔任資深研發工作，發表超過70篇免疫相關論文及專利，2022年8月起任藥華醫藥科學長，以其免疫治療與炎症研究的專業，領導研發團隊新藥研發，加速公司的進展。
Time: 2023/03/30 (Thu.) 10:30 am -12:00 pm
Venue: Intl. Conf. Hall (Rm. 201), Bldg. C, NBRP 國家生技研究園區C棟國際會議廳
Speaker: Dr. Lih-Ling Lin (Chief Scientific Officer, PharmaEssentia Corp.) 藥華醫藥林俐伶科學長
Moderator: Dr. Han-Chung Wu (Director, BioTReC, Academia Sinica)
Registration: https://forms.gle/NCiJS59yNaRwevGV6
